216 related articles for article (PubMed ID: 36899935)
1. Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration.
Lin LW; Wang SW; Huang WC; Huynh TK; Lai CY; Ko CY; Fong YC; Lee JJ; Yang SF; Tang CH
Cells; 2023 Mar; 12(5):. PubMed ID: 36899935
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial and progenitor cells in age-related macular degeneration.
Mucciolo DP; Marcucci R; Sodi A; Cesari F; Murro V; Rogolino A; Rizzo S; Giusti B; Virgili G; Prisco D; Gori AM
Eur J Ophthalmol; 2020 Sep; 30(5):956-965. PubMed ID: 31328962
[TBL] [Abstract][Full Text] [Related]
3. SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.
Enseleit F; Michels S; Sudano I; Stahel M; Zweifel S; Schlager O; Becker M; Winnik S; Nägele M; Flammer AJ; Neidhart M; Graf N; Matter CM; Seifert B; Lüscher TF; Ruschitzka F
Ophthalmologica; 2017; 238(4):205-216. PubMed ID: 28866675
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
5. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Cho HJ; Park SM; Kim J; Nah SK; Lee J; Lee DW; Kim JW
Acta Ophthalmol; 2021 Jun; 99(4):e540-e546. PubMed ID: 32996674
[TBL] [Abstract][Full Text] [Related]
6. Atypical macular hole formation after Anti-VEGF therapy for neovascular age-related macular degeneration: Coincidence or consequence?
Kayaarasi Ozturker Z; Akca Bayar S; Yaman Pinarci E; Kurt RA; Akkoyun I; Yilmaz G
Arch Soc Esp Oftalmol (Engl Ed); 2021 Sep; 96(9):455-461. PubMed ID: 34479701
[TBL] [Abstract][Full Text] [Related]
7. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
8. Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration.
Chandra S; Arpa C; Menon D; Khalid H; Hamilton R; Nicholson L; Pal B; Fasolo S; Hykin P; Keane PA; Sivaprasad S
Eye (Lond); 2020 Oct; 34(10):1888-1896. PubMed ID: 31980748
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
[TBL] [Abstract][Full Text] [Related]
10. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
Liisborg C
Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
[TBL] [Abstract][Full Text] [Related]
11. Current therapeutic approaches in neovascular age-related macular degeneration.
Nguyen DH; Luo J; Zhang K; Zhang M
Discov Med; 2013 Jun; 15(85):343-8. PubMed ID: 23819948
[TBL] [Abstract][Full Text] [Related]
12. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
Ferrara N; Damico L; Shams N; Lowman H; Kim R
Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Aflibercept as initial treatment for neovascular age-related macular degeneration in an Iraqi patient sample.
Hussein ZR; Omar SK; Alkazraji RAM; Alsamarrai AN; Alrubaye HS; Al-Hussaniy HA
J Med Life; 2023 Feb; 16(2):235-243. PubMed ID: 36937463
[TBL] [Abstract][Full Text] [Related]
14. Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration.
ElSheikh RH; Chauhan MZ; Sallam AB
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358978
[TBL] [Abstract][Full Text] [Related]
15. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
Lu X; Sun X
Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
[TBL] [Abstract][Full Text] [Related]
16. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenesis by dual action of R5K peptide conjugated itraconazole nanoparticles.
Chittasupho C; Kengtrong K; Chalermnithiwong S; Sarisuta N
AAPS PharmSciTech; 2020 Jan; 21(3):74. PubMed ID: 31965399
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration.
Ding K; Eaton L; Bowley D; Rieser M; Chang Q; Harris MC; Clabbers A; Dong F; Shen J; Hackett SF; Touw DS; Bixby J; Zhong S; Benatuil L; Bose S; Grinnell C; Preston GM; Iyer R; Sadhukhan R; Marchie S; Overmeyer G; Ghayur T; van Riet DA; Tang S; Campochario PA; Gu J
MAbs; 2017; 9(2):269-284. PubMed ID: 27929753
[TBL] [Abstract][Full Text] [Related]
19. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
[TBL] [Abstract][Full Text] [Related]
20. Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy.
Wood E; Chang JS; Flynn HW; Kitchens JW
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):175-8. PubMed ID: 24512809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
